The targeted disruption of the CD98 gene results in embryonic lethality.

[1]  D. Hartshorne,et al.  Role of Protein Phosphatase Type 1 in Contractile Functions: Myosin Phosphatase* , 2004, Journal of Biological Chemistry.

[2]  D. Hartshorne,et al.  Myosin phosphatase: Structure, regulation and function , 2004, Molecular and Cellular Biochemistry.

[3]  A. Somlyo,et al.  Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. , 2003, Physiological reviews.

[4]  Patricia T W Cohen,et al.  Protein phosphatase 1--targeted in many directions. , 2002, Journal of cell science.

[5]  J. White,et al.  Sequence-specific interaction between the disintegrin domain of mouse ADAM 3 and murine eggs: role of beta1 integrin-associated proteins CD9, CD81, and CD98. , 2001, Molecular biology of the cell.

[6]  T. Ishii,et al.  Cloning and Expression of a Plasma Membrane Cystine/Glutamate Exchange Transporter Composed of Two Distinct Proteins* , 1999, The Journal of Biological Chemistry.

[7]  Y. Ito,et al.  Cutting edge: primary structure of the light chain of fusion regulatory protein-1/CD98/4F2 predicts a protein with multiple transmembrane domains that is almost identical to the amino acid transporter E16. , 1999, Journal of immunology.

[8]  G. Borsani,et al.  SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance , 1999, Nature Genetics.

[9]  L. Kühn,et al.  Amino acid transport of y+L‐type by heterodimers of 4F2hc/CD98 and members of the glycoprotein‐associated amino acid transporter family , 1999, The EMBO journal.

[10]  C. Shoemaker,et al.  Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family , 1998, Nature.

[11]  Eiji Takeda,et al.  Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)* , 1998, The Journal of Biological Chemistry.

[12]  J. Ramos,et al.  Complementation of dominant suppression implicates CD98 in integrin activation , 1997, Nature.

[13]  M. Tsurudome,et al.  Induction of Human Osteoclast‐like Cells by Treatment of Blood Monocytes with Anti‐Fusion Regulatory Protein‐1/CD98 Monoclonal Antibodies , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  A. Wissmann,et al.  Caenorhabditis elegans LET-502 is related to Rho-binding kinases and human myotonic dystrophy kinase and interacts genetically with a homolog of the regulatory subunit of smooth muscle myosin phosphatase to affect cell shape. , 1997, Genes & development.

[15]  X. Estivill,et al.  Genetic heterogeneity in cystinuria: the SLC3A1 gene is linked to type I but not to type III cystinuria. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Palacín,et al.  A new family of proteins (rBAT and 4F2hc) involved in cationic and zwitterionic amino acid transport: a tale of two proteins in search of a transport function. , 1994, The Journal of experimental biology.

[17]  J. Shelhamer,et al.  Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. , 1981, Journal of immunology.

[18]  M. Tsurudome,et al.  Expression and regulation of 4F2hc and hLAT1 in human trophoblasts. , 2002, American journal of physiology. Cell physiology.

[19]  Fox Da,et al.  A role for CD98 in cellular activation , 1998 .